Cefixime 200 mg + Ofloxacin 200 mg
| Composition | Cefixime 200 mg + Ofloxacin 200 mg |
|---|---|
| Packing | 10x10 Alu/Alu |
| MRP | ₹ 1860 |
| Dosage Form | Tablets |
Cefzia-O Tablet is a powerful dual-antibiotic combination containing Cefixime 200 mg and Ofloxacin 200 mg. By combining a third-generation cephalosporin with a fluoroquinolone, this tablet delivers a broader spectrum of antibacterial activity than either drug alone, making it effective against a wide variety of infections that may involve multiple or resistant organisms.
Biozia Lifesciences formulates Cefzia-O for clinical use in infections where broader coverage is required. The combination is particularly valued in typhoid fever, complicated urinary tract infections, and gastrointestinal infections where gram-positive, gram-negative, and intracellular organisms may all be involved.
This medicine is commonly used for:
The combination of Cefixime and Ofloxacin is indicated for the treatment of infections requiring broad-spectrum and intracellular coverage, including enteric fever (Salmonella typhi), complicated urinary tract infections (including pyelonephritis), acute exacerbations of chronic bronchitis, community-acquired pneumonia with atypical organisms (Chlamydia pneumoniae, Mycoplasma pneumoniae), and mixed aerobic-anaerobic soft tissue infections.
Cefzia-O fights bacterial infections using two different mechanisms working together. Cefixime targets and destroys the bacterial cell wall, while ofloxacin targets the DNA machinery inside the bacteria, preventing them from copying themselves. This two-pronged attack makes it very difficult for bacteria to survive or develop resistance, providing comprehensive infection clearance.
Cefixime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing peptidoglycan cross-linking and causing osmotic lysis of susceptible organisms. Ofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV — enzymes essential for DNA replication, transcription, repair, and recombination — leading to bactericidal double-strand DNA breaks. The complementary and synergistic mechanisms of these two antibiotics extend coverage to gram-negative enteric organisms, gram-positives, and atypical intracellular pathogens.
The combination of a cephalosporin plus a fluoroquinolone is one of the most commonly recommended regimens for treating typhoid fever in India, where multidrug-resistant Salmonella typhi strains have reduced the effectiveness of older single antibiotics like chloramphenicol and ampicillin.
Take Cefzia-O as prescribed by your doctor — usually taken with or without food, at regular intervals to maintain constant levels in the body. Stay well hydrated during treatment. Do not stop taking the medicine before completing the full prescribed course.
Always follow the dosage and schedule advised by your doctor — this is general guidance only.
Some patients may experience nausea, diarrhoea, stomach pain, headache, or dizziness. Fluoroquinolones may occasionally cause tendon sensitivity, particularly in older adults — consult your doctor if you notice joint or tendon pain. Skin sensitivity to sunlight may increase during treatment. Tell your doctor if any side effect is severe or persistent.
A stronger combination antibiotic is always better than a single antibiotic.
Combination antibiotics are prescribed for specific infections that genuinely require broader coverage. Using them unnecessarily increases the risk of side effects and promotes antibiotic resistance. Always use antibiotics only on a doctor's prescription.
You can take antacids with this tablet to prevent stomach upset.
Antacids containing aluminium, magnesium, or calcium can bind to ofloxacin in the gut and significantly reduce its absorption, making the antibiotic less effective. Always space antacids and fluoroquinolone antibiotics apart as advised by your doctor.